Ritu Chaudhary

5PUBLICATIONS
56CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 21, 2025
Long-term Survival and Molecular Biomarker Evaluation of a Phase II Cetuximab and Nivolumab Clinical Trial in Recurrent/Metastatic Head and Neck Cancer.

Ritu Chaudhary, Graydon Moorhead, Robin Park

|Jul 11, 2025
Plasma Cell-Free Human Papillomavirus DNA and Oral Gargle HPV DNA in Patients with HPV-Related Oropharyngeal Cancer Treated with Radiotherapy.

Michelle Echevarria, Robin Park, Jimmy J Caudell

|Jun 24, 2025
PV-10 Triggers Immunogenic Cell Death in Head and Neck Squamous Cell Carcinoma via Endoplasmic Reticulum Stress and Apoptosis.

Sowjanya Thatikonda, Ritu Chaudhary, Yeva Meshkovska

|Aug 21, 2024
Pembrolizumab and Cabozantinib in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Long-term Survival Update with a Biomarker Analysis.

Nabil F Saba, Ritu Chaudhary, Kedar Kirtane

|Jun 28, 2023
EGFR Inhibition by Cetuximab Modulates Hypoxia and IFN Response Genes in Head and Neck Squamous Cell Carcinoma.

Ritu Chaudhary, Robbert J C Slebos, Leenil C Noel

Pageof 1

Frequent Collaborators

5 joint publications

Christine H Chung

4 joint publications

Robbert J C Slebos

4 joint publications

Maria I Poole

3 joint publications

Antonio L Amelio